Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody. [PDF]
Zaninelli S +13 more
europepmc +1 more source
CAR-T cell immunotherapy in rhabdomyosarcoma. [PDF]
Safarzadeh Kozani P +2 more
europepmc +1 more source
Cannabidiol in pancreatic ductal adenocarcinoma: preclinical evidence, molecular mechanisms, and translational challenges. [PDF]
Esmaeli M +2 more
europepmc +1 more source
Case Report: Three cases with allogeneic CIK therapy against solid tumors. [PDF]
Li Y +5 more
europepmc +1 more source
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation. [PDF]
De Maria R +18 more
europepmc +1 more source
Tumor-priming CD8<sup>+</sup> natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myeloma. [PDF]
Lee J +13 more
europepmc +1 more source
The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes. [PDF]
Giordano G +19 more
europepmc +1 more source
Hnf4α integrates AIF and caspase 3/9 signaling to restrict single and coinfecting pathogens in teleosts. [PDF]
Yan D +5 more
europepmc +1 more source
The Liver Week 2025 Highlights: Celebrating the 30th Anniversary of the Korean Association for the Study of the Liver. [PDF]
Chon YE +11 more
europepmc +1 more source

